Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Kreate Biotechnology is a specialized molecular diagnostics company based in Guangzhou, China, focusing on the development and commercialization of Fluorescence In Situ Hybridization (FISH) technology. The company provides a comprehensive portfolio of high-performance FISH probes and automated hybridization instruments used for the detection of genetic biomarkers in oncology and medical genetics. Their products are essential for identifying chromosomal translocations, amplifications, and deletions, supporting clinicians in cancer diagnosis, prognosis, and the selection of targeted therapies. Guangzhou Kreate Biotechnology serves a wide range of clinical and research institutions, playing a key role in the advancement of precision oncology and personalized medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Kreate Biotechnology.